First lung and kidney multi-organ transplant following COVID-19 Infection

JOURNAL OF HEART AND LUNG TRANSPLANTATION

卷:40

Editorial Material

Guenthart, Brandon A.¹  Krishnan, Aravind¹  Alassar, Aiman¹  Madhok, Jai²  Kakol, Monika³  Miller, Shari¹  Cole, Sheela Pai²  Rao, Vidya K.²  Acero, Natalia Martinez²  Hill, Charles C.²  Cheung, Cindy²  Jackson, Ethan C.²  Feinstein, Igor²  Tsai, Albert H.²  Pham, Thomas⁴  Elliott, Irmina A.¹  Liou, Douglas Z.¹  La Francesca, Saverio¹  Shudo, Yasuhiro¹  Hiesinger, William¹  MacArthur, John W.¹  Brar, Nivaz⁵  Berry, Gerald J.⁵  McCarra, Matthew B.^3,6  Desai, Tushar J.^3,6  Dhillon, Gundeep S.³  Woo, Y. Joseph¹ 

[1] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA

[2] Stanford Univ, Dept Anesthesiol Perioperative & Pain Med, Stanford, CA 94305 USA

[3] Stanford Univ, Dept Med, Div Pulm Allergy & Crit Care, Stanford, CA 94305 USA

[4] Stanford Univ, Dept Surg, Div Abdominal Transplantat, Stanford, CA 94305 USA

[5] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA

[6] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA

关键词: multi-organ transplant;    COVID-19;    lung transplant;    kidney transplant;    ECMO;   

DOI  :  10.1016/j.healun.2021.02.015

来源: Elsevier

【 摘 要 】

As the world responds to the global crisis of the COVID-19 pandemic an increasing number of patients are experiencing increased morbidity as a result of multi-organ involvement. Of these, a small proportion will progress to end-stage lung disease, become dialysis dependent, or both. Herein, we describe the first reported case of a successful combined lung and kidney transplantation in a patient with COVID-19. Lung transplantation, isolated or combined with other organs, is feasible and should be considered for select patients impacted by this deadly disease. (C) 2021 International Society for Heart and Lung Transplantation. All rights reserved.

【 授权许可】

Free